Share

    


Home / Search Results

Search Results

Search Again?

Filter By Topic

You searched for:

Immunotherapy in Non-Small Cell Lung Cancer Immunotherapy in Non-Small Cell Lung Cancer Renato G Martins, MD, MPH Stephen H. Petersdorf Chair in Cancer Care Medical Director Thoracic/Head and Neck Medical Oncology Professor University of Washington; Seattle Cancer Care Alliance ICLIO 1st Annual National Conference 10.2.15 Philadelphia, Pa. …
ICLIO National Conference ICLIO National Conference Igor Puzanov, MD, MSCI, FACP. Director of Early Phase Clinical Trials Program Roswell Park Cancer Institute, Buffalo NY Immuno-Oncology Indications and Combinations 9.30.16 Philadelphia, Pa. accc-iclio.org • Consultancy: – Amgen – Roche • Research Grant Support to Institution: – Nektar …
Hormone receptor-positive breast cancer Ruth O’Regan, MD Chair and Charles A. Dewey Professor, Department of Medicine Associate Director for Education and Mentoring, Wilmot Cancer Institute University of Rochester Disclosures I have served as an advisor for PUMA, Lilly, Pfizer, Seagen, Novartis, Astra-Zeneca and have served on DSMB for Gilead All slides included …
Hormone receptor-positive breast cancer Ruth O’Regan, MD Chair and Charles A. Dewey Professor, Department of Medicine Associate Director for Education and Mentoring, Wilmot Cancer Institute University of Rochester Disclosures I have served as an advisor for PUMA, Lilly, Pfizer, Seagen, Novartis, Astra-Zeneca and have served on DSMB for Gilead All slides included …
Payer-Oncologist Relationships: Recommendations for Improvement Full Terms & Conditions of access and use can be found at https://www.tandfonline.com/action/journalInformation?journalCode=uacc20 Oncology Issues ISSN: 1046-3356 (Print) 2573-1777 (Online) Journal homepage: https://www.tandfonline.com/loi/uacc20 Payer-Oncologist Relationships: Recommendations for Improvement Cary …
Désirée Ratner, MD Clinical Professor of Dermatology NYU Langone Health February 19, 2020 High Risk Cutaneous Squamous Cell Carcinoma: Recognition and Management • Advisory Board, Regeneron-Sanofi • Speaker Bureau, Genentech Disclosures • Following this session, attendees should be able to: •  1) identify lesions suspicious for cutaneous squamous cell …
SABCS 2022: Radiation Oncology Highlights Bethany Anderson, MD Associate Professor, Radiation Oncology University of WI Objectives • Discuss two abstracts studying hypofractionation (one 2D, one protons) & place these into clinical context. • Discuss one abstract studying a novel gene signature to identify candidates for radiotherapy omission & place this into clinical …
PowerPoint Presentation Thyroid and Salivary Cancer Updates Prakash Neupane MD 3, 10, 11, 12, 15, 16, 20, 23, 24, 25, 27, 28, 29, 33, 34, 37, 38, 39, 42, 43. Salivary Gland cancer Occurs in glands of: »Parotid »Submandibular »Sublingual »Minor salivary glands Salivary Gland cancer Fewer than 10% of epithelial H&N cancers. Association with prior Radiation …
PowerPoint Presentation Ravi Salgia, MD, PhD Professor and Chair Department of Medical Oncology and Therapeutics Research Precision Medicine in Metastatic NSCLC CITY OF HOPE Objectives  Precision Medicine at City of Hope  Lung Cancer Overview  Precision Medicine Overview  Therapeutic Strategies  Germline Testing and Strategies  Artificial Intelligence …
PowerPoint Presentation Risk factors for positive margin in breast conservative surgery for localized breast cancer James Ferrick DO¹, Hina Zubair MD¹, Sumeet Salvi OMS-IV², Elaine A Davis RN, MS, EdD¹, Christine A Welch MS¹, Amir S Kamran MD, MS³ ¹ CAMC Institute for Academic Medicine, Charleston, WV ² West Virginia School of Osteopathic Medicine, Lewisburg, WV ³ Department of …
Texas Society of Clinical Oncology Annual Conference 2023 Presented By: Laith Abushahin MBBS @LAbushahin Updates in Gastrointestinal Malignancies Laith Abushahin MBBS Texas Oncology Baylor Charles A Sammons Cancer Center Dallas, Texas Gastrointestinal Malignancies 2023 estimates: • ~ 340 k new Cases. ~ 166 k deaths in 2023 in USA.1 • ~ 12,260 cancer deaths out of …
PowerPoint Presentation ASCO Direct Highlights: Lymphoma/Leukemia Brian Hess, MD 8.7.21 Disclosure of Conflict(s) of Interest Brian Hess, MD reported the following relevant financial relationships or relationships with ineligible companies of any amount during the past 24 months. • Consultant: ADC Therapeutics. • Speaker’s Bureau: AstraZeneca, Bristol Myers …
Slide 1 accc-iclio.org accc-iclio.org accc-iclio.org Therapeutic Approaches to Metastatic Melanoma Sanjiv Agarwala, MD Professor of Medicine St Luke’s Cancer Center, Temple University accc-iclio.org Objectives • Introduction and Background • Questions I ask myself in the clinic • Future Directions accc-iclio.org The Transformed Landscape …
PowerPoint Presentation UPDATE ON ENGINEERED CELL THERAPIES: CAR-T AND BEYOND Stephan Grupp, MD, PhD Director, Susan S. and Stephan P. Kelly Center for Cancer Immunotherapy Disclosures • Research and/or clinical trial support from Novartis, Servier, Vertex and Kite • Study steering committees, consulting, or scientific advisory boards: Novartis, Allogene, …
Updates in Leukemia Prajwal Dhakal, MBBS Prajwal Dhakal, MBBS Clinical Assistant Professor Division of Hematology, Oncology, Blood & Marrow Transplantation University of Iowa Acute lymphoblastic leukemia PhALLCON: Phase III study comparing Ponatinib vs Imatinib in Philadelphia chromosome positive ALL • Newly diagnosed Ph+ ALL • Ponatinib 30 mg …
CAR T-cell Therapy: The Past, The Present, and The Future Clark Alsfeld, MD Attending Physician Ochsner Health Disclosure of Conflicts of Interest Consultant – Janssen Biotech; CTI Biopharma Learning Objectives •Understand the current state of CAR T-cell therapy in hematologic malignancies •Know what to expect for CART in the community •Review future directions …
ALEE_NMSCO_10-6-22 10/6/2022 1 Benefits of Proton Therapy… As Prevention of Radiation Toxicity and the Mechanics of New Technology Andrew K. Lee, M.D., MPH Medical Director Texas Center for Proton Therapy 2 Andrew K. Lee, MD, MPH has the following financial relationship to disclose: Consultant and on speaker bureau for Tolmar Pharmaceuticals This presentation will …
PowerPoint Presentation Fig 1. Antibiotic exposures. Antibiotic exposures by day +14 (A) and +100 (B). Antibacterial antibiotic exposures and cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation Shijia Zhang MD, PhD1, Ryan Shanley MS2, and Armin Rashidi MD, PhD1 1Division of Hematology, Oncology and Transplantation, Department of Medicine, University …
LEGISLATION & LUNCH E N T R É E C O U R S E O N E : ADVOCACY FOR LUNCH T O M M C C O Y , J D E X E C U T I V E D I R E C T O R - S T A T E G O V E R N M E N T A F F A I R S N E V A D A C H R O N I C C A R E C O L L A B O R A T I V E ABOU T NCCC The Nevada Chronic Care Collaborative is an alliance of non- profit health organizations, physician, provider, and …
PowerPoint Presentation Integrative Medicine in Hematology-Oncology Shaunak Pandya, MD Hematology-Oncology Fellow Integrative Medicine in Hematology-Oncology Fellow University of Arizona - Tucson Overview • Integrative Medicine • Introduction to IMHO Fellowship • Research – IIT: Yoga in Multiple Myeloma What is Integrative Medicine? "Integrative medicine …